RPS6KB1 and sarcoma: Histopathological analysis at human endpoint of the different mouse cohorts showed a decreased lymphoma incidence in S6k1−/−Terc+/+ mice compared to S6k1+/+Terc+/+ mice while no difference was observed in the frequency of sarcoma (Supplementary Fig. 7D–E).